VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2021

May 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2021-05-01

Reporting Person: Bhatia Sangeeta N. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-01	Common Stock	A	1842	$0.00	Acquired	5750	Direct

Footnotes

F1: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.